Download Unicorn Signals App

Powered By EquityPandit
 Signals, Powered By  EquityPandit
Latest News

Unichem Lab has got USFDA approval for hypertension drug

The US health regulator has provided its final approval to Unichem Laboratories to market generic Irbesartan tablets that are used in treating hypertension, in the American market.

Unichem Laboratories said in a BSE filing that the company has received final abbreviated new drug application (ANDA) approval from the US Food and Drug Administration (USFDA) for Irbesartan tablets.

It said that “The product would be commercialized from Unichem’s Ghaziabad plant. Active Pharmaceutical Ingredient (API) for the product would also made in-house at Pithampur plant”.

Read EquityPandit’s Technical Analysis on Nifty Pharma 

Get Daily Prediction & Stocks Tips On Your Mobile